Amidst the backdrop of global economic uncertainty and central banks maintaining steady interest rates, Asian markets have shown resilience, with investors closely monitoring developments in major economies like China and Japan. Penny stocks, while often considered a relic of past trading eras, continue to capture attention due to their potential for growth and affordability. These smaller or newer companies can offer significant opportunities when they demonstrate financial strength, making them an intriguing option for those looking to uncover hidden value in today's market landscape.
Top 10 Penny Stocks In Asia
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Guoquan Food (Shanghai) (SEHK:2517) |
HK$3.30 |
HK$8.66B |
★★★★★★ |
| Yonghe Medical Group (SEHK:2279) |
HK$2.05 |
HK$1.03B |
★★★★★★ |
| Lever Style (SEHK:1346) |
HK$1.41 |
HK$873.99M |
★★★★★★ |
| Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC) |
THB4.58 |
THB1.9B |
★★★★★★ |
| PC Partner Group (SGX:PCT) |
SGD2.18 |
SGD845.59M |
★★★★★★ |
| CNMC Goldmine Holdings (Catalist:5TP) |
SGD1.42 |
SGD575.51M |
★★★★★★ |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) |
SGD4.14 |
SGD16.29B |
★★★★★☆ |
| TeleChoice International (SGX:T41) |
SGD0.24 |
SGD108.72M |
★★★★★☆ |
| Scott Technology (NZSE:SCT) |
NZ$2.30 |
NZ$193.42M |
★★★★★☆ |
| Lee Feed Mill (SET:LEE) |
THB2.44 |
THB2.17B |
★★★★★★ |
Click here to see the full list of 957 stocks from our Asian Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Meitu
Simply Wall St Financial Health Rating:★★★★★☆
Overview:Meitu, Inc. is an investment holding company that develops and provides AI-powered products for photo, video, and design production in Mainland China and internationally, with a market cap of HK$21.21 billion.
Operations:The company's revenue segment includes an Internet Business generating CN¥3.86 billion.
Market Cap:HK$21.21B
Meitu's recent developments highlight its strategic focus on AI innovation with the launch of RoboNeo, an advanced imaging AI agent designed to streamline content creation. Despite a robust revenue stream of CN¥3.86 billion, the company experienced a dip in net income to CN¥582.9 million last year, partly due to large one-off gains previously boosting results. While Meitu's debt levels are manageable and well-covered by operating cash flow, its earnings growth has slowed recently compared to industry peers. The ongoing share repurchase program could enhance shareholder value by increasing earnings per share and net asset value over time.
Pubang Landscape Architecture
Simply Wall St Financial Health Rating:★★★★★★
Overview:Pubang Landscape Architecture Co., Ltd operates in China, focusing on garden engineering construction and landscape design, with a market cap of CN¥4.07 billion.
Operations:Revenue Segments: No Revenue Segments Reported.
Market Cap:CN¥4.07B
Pubang Landscape Architecture faces financial challenges, with a net loss of CN¥464.79 million for 2025, slightly improved from the previous year. Despite this, the company maintains a strong cash position, with short-term assets of CN¥2.7 billion exceeding both short and long-term liabilities, indicating robust liquidity management. The debt-to-equity ratio has improved over five years to 12.4%, reflecting prudent financial strategies. However, volatility remains high and profitability elusive as losses persist despite reduced debt levels and no significant shareholder dilution recently. The seasoned management team offers stability amidst these ongoing operational hurdles in a competitive landscape design market.
Zhejiang Sunflower Great Health
Simply Wall St Financial Health Rating:★★★★☆☆
Overview:Zhejiang Sunflower Great Health Co., Ltd. operates in the healthcare sector and has a market cap of CN¥5.11 billion.
Operations:Zhejiang Sunflower Great Health Co., Ltd. does not report specific revenue segments.
Market Cap:CN¥5.11B
Zhejiang Sunflower Great Health Co., Ltd. is navigating financial challenges, having reported a net loss of CN¥5.22 million for Q1 2026, with revenue declining to CN¥54.56 million from the previous year. Despite being unprofitable and experiencing increased losses over five years, the company maintains strong liquidity; its short-term assets of CN¥772 million exceed both short and long-term liabilities significantly, indicating solid financial management without debt concerns. The seasoned management team provides stability in this volatile market environment where shareholder dilution has been minimal despite ongoing operational hurdles in achieving profitability within the healthcare sector.
Next Steps
-
Get an in-depth perspective on all 957 Asian Penny Stocks by using our screener here.
-
Searching for a Fresh Perspective? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:1357 SZSE:002663 and SZSE:300111.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
